Health
Chinese COVID-19 vaccine shows promising trial results: research paper – Xinhua | English.news.cn – Xinhua
BEIJING, Aug. 16 (Xinhua) — An inactivated COVID-19 vaccine candidate developed by China is safe and generates an immune response, according to data from clinical trials published in The Journal of the American Medical Association this week.
The research paper provided an interim analysis of the phase-1 and phase-2 clinical trials of an inactivated COVID-19 vaccine developed by the Wuhan Institute of Biological Products under the China National Biotec Group (CNBG), affiliated to Sinopharm, and…
-
Business24 hours agoASX 200 company jumps 5% on sale of Fertilisers Distribution business
-
Business17 hours agoMacquarie tips 60%+ return for this ASX All Ords stock
-
Business20 hours agoWhy Morgans upgraded TPG, ANZ Bank, and this ASX share
-
Noosa News15 hours agoJarred Drew Heath pleads guilty after pointing replica gun at police in Gatton caravan park